title: Hemolytic-uremic syndrome in a patient with chronic myelogenous leukemia treated with interferon alpha.
authors.forename: D
authors.initials: D
authors.lastname: Schlaifer
authors.forename: P
authors.initials: P
authors.lastname: Dumazer
authors.forename: N
authors.initials: N
authors.lastname: Spenatto
authors.forename: M
authors.initials: M
authors.lastname: Mignon-Conte
authors.forename: P
authors.initials: P
authors.lastname: Brousset
authors.forename: C
authors.initials: C
authors.lastname: Lumbroso
authors.forename: M
authors.initials: M
authors.lastname: Cooper
authors.forename: C
authors.initials: C
authors.lastname: Muller
authors.forename: F
authors.initials: F
authors.lastname: Huguet
authors.forename: M
authors.initials: M
authors.lastname: Attal
mesh_terms: D000328:Adult; D006463:Hemolytic-Uremic Syndrome / Q000209:etiology*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications* / Q000188:drug therapy*; D008297:Male
chemical_list: D016898:Interferon-alpha